Q2 2021 X4 Pharmaceuticals Inc Earnings Call Transcript
Greetings and welcome to X4 Pharmaceuticals Second Quarter Financial and Operating Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Carey Gallant of LifeSci Advisors. Please begin.
Thank you, operator, and good morning, everyone. Thanks for joining us. Presenting on today's call will be X4's Chief Executive Officer, Dr. Paula Ragan; and the company's Chief Financial Officer, Adam Mostafa. Following prepared remarks by each, we will open the call to your questions, and we will be joined by Chief Scientific Officer, Art Taveras; and Mary DiBiase, Senior Vice President Technical Operations and Quality.
As a reminder, on today's call, the company will be making forward-looking statements regarding regulatory and product development plans as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |